Volume 63, Issue 2, Pages (February 2003)

Slides:



Advertisements
Similar presentations
Volume 66, Issue 5, Pages (November 2004)
Advertisements

Volume 66, Issue 5, Pages (November 2004)
Volume 64, Issue 6, Pages (December 2003)
Volume 65, Issue 1, Pages (January 2004)
Volume 66, Issue 3, Pages (September 2004)
Volume 60, Issue 4, Pages (October 2001)
Volume 84, Issue 3, Pages (September 2013)
Volume 132, Issue 3, Pages (March 2007)
Kuo-Jung Li, Ai-Li Shiau, Yuan-Yow Chiou, Yi-Te Yo, Chao-Liang Wu 
Volume 62, Issue 6, Pages (December 2002)
Cyclic nucleotide signaling in polycystic kidney disease
Volume 84, Issue 5, Pages (November 2013)
Selective impairment in glycogen synthase kinase-3 and mitogen-activated protein kinase phosphorylation: comparisons with the hyperandrogenic and the.
Somatostatin, Estrogen, and Polycystic Liver Disease
Volume 132, Issue 3, Pages (March 2007)
Volume 91, Issue 3, Pages (March 2017)
Volume 73, Issue 3, Pages (February 2008)
Li Cui, Raymond K. Blanchard, Robert J. Cousins  Kidney International 
David A. Cano, Shigeki Sekine, Matthias Hebrok  Gastroenterology 
Volume 67, Issue 3, Pages (March 2005)
Volume 78, Issue 8, Pages (October 2010)
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy  J.-A. Moon,
Volume 60, Issue 2, Pages (August 2001)
Volume 54, Issue 2, Pages (August 1998)
Istvan Arany, Judit K. Megyesi, Jane E.B. Reusch, Robert L. Safirstein 
Volume 61, Issue 5, Pages (May 2002)
Sayu Omori, Ryuji Fukuzawa, Mariko Hida, Midori Awazu 
Volume 67, Issue 3, Pages (March 2005)
Volume 67, Issue 2, Pages (February 2005)
Ralph Witzgall, Bettina Kränzlin, Norbert Gretz, Nicholas Obermüller 
Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes  Lesley Wassef, Darren J. Kelly, Richard E. Gilbert 
Fenghua Zeng, Tomoki Miyazawa, Lance A. Kloepfer, Raymond C. Harris 
Volume 56, Issue 5, Pages (November 1999)
Volume 59, Issue 1, Pages (January 2001)
Volume 61, Issue 6, Pages (June 2002)
Volume 54, Issue 1, Pages (July 1998)
ANO1: an additional key player in cyst growth
VEGF receptor 2 blockade leads to renal cyst formation in mice
Xue-Hui Liu, Achim Aigner, Anton Wellstein, Patricio E. Ray 
The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy  Yoichi Miyazaki, Shinya Tsuchida, Agnes Fogo,
Volume 68, Issue 4, Pages (October 2005)
Volume 85, Issue 5, Pages (May 2014)
Prenatal programming of adult hypertension in the rat
Volume 58, Issue 2, Pages (August 2000)
Volume 64, Issue 4, Pages (October 2003)
Volume 81, Issue 8, Pages (April 2012)
Volume 79, Issue 9, Pages (May 2011)
Volume 57, Issue 5, Pages (May 2000)
Treatment of chronic tubulointerstitial disease: A new concept
Gregory B. Vanden Heuvel  Kidney International 
Let's look at cysts from both sides now
Volume 54, Issue 2, Pages (August 1998)
Volume 60, Issue 6, Pages (December 2001)
Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury  Jianchun Chen, Jian-Kang.
Volume 63, Issue 4, Pages (April 2003)
Volume 59, Issue 3, Pages (March 2001)
Volume 65, Issue 2, Pages (February 2004)
Autosomal dominant polycystic kidney disease: the last 3 years
Volume 57, Issue 4, Pages (April 2000)
Volume 73, Issue 9, Pages (May 2008)
Volume 83, Issue 6, Pages (June 2013)
Volume 54, Issue 3, Pages (September 1998)
Harold M. Aukema, Ihsan Housini  Kidney International 
Volume 61, Issue 4, Pages (April 2002)
Volume 57, Issue 1, Pages (January 2000)
Volume 72, Issue 11, Pages (December 2007)
The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?  Richard E. Gilbert, Mark E. Cooper  Kidney.
Larry D. Alexander, Suganthi Alagarsamy, Janice G. Douglas 
Volume 55, Issue 2, Pages (February 1999)
Volume 66, Issue 5, Pages (November 2004)
Presentation transcript:

Volume 63, Issue 2, Pages 427-437 (February 2003) Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease  Shizuko Nagao, Tamio Yamaguchi, Masatomo Kusaka, Robin L. Maser, Hisahide Takahashi, Benjamin D. Cowley, Jared J. Grantham  Kidney International  Volume 63, Issue 2, Pages 427-437 (February 2003) DOI: 10.1046/j.1523-1755.2003.00755.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Progression of polycystic disease in the Han:SPRD rat. Mid-coronal hemisections stained with hematoxylin and eosin. Cystic changes were detected in the cortex of 3-week-old male Cy/+ animals. Cy/Cy kidneys of either sex were greatly enlarged and cystic at 3 weeks of age. The Cy/Cy animals were sacrificed at 3 weeks of age. In 8-week-old animals, cystic progression was greater in male than in female Cy/+. At 8 weeks, the serum urea nitrogen levels were slightly elevated in males and normal in females27. Kidney International 2003 63, 427-437DOI: (10.1046/j.1523-1755.2003.00755.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Expression of extracellular-related kinase (ERK) pathway proteins. Kidneys of two normal male (+/+) and two cystic male (Cy/+) animals from the same litter at 8 weeks of age. Western blots of phosphorylated ERK (P-ERK), B-Raf, phosphorylated (P-Raf-1) and Raf-1 are shown with respective molecular weights of these components. (A) P-ERK was expressed to a greater extent in Cy/+ than in +/+ kidneys. A third band of P-ERK of higher molecular weight than p44 was consistently seen in male Cy/+ and male and female Cy/Cy kidneys (data not shown), and to a much lesser extent in +/+ animals of either sex. ERK expression was not appreciably different between +/+ and Cy/+ animals. (B) B-Raf abundance was increased in Cy/+ in comparison to +/+ animals. (C) P-Raf-1 and Raf-1 levels were increased in Cy/+ in comparison to +/+ animals. Kidney International 2003 63, 427-437DOI: (10.1046/j.1523-1755.2003.00755.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Phosphorylated extracellular-related kinase (P-ERK) and ERK expression in 8-week-old male +/+ and Cy/+ kidneys. (A) ERK expression in +/+. Proximal tubules stained weakly and distal tubules exhibited greater intensity. (B) P-ERK was not expressed to a remarkable degree in +/+. (C to I) are from the same region of a male Cy/+ kidney and were selected to show portions of normal tubules undergoing cystic transformation. (C) P-ERK expression in patches of epithelial cells (arrows) lining cysts. No P-ERK expression observed in noncystic structures. (D) Higher power view of C showing P-ERK expression in patches of epithelial cells lining cysts (arrows) and the transition (*) between abnormal P-ERK expressing cells and adjacent cells of more normal phenotype. Tubule basement membrane is thickened beneath P-ERK expressing cells and the subjacent interstitium is widened and infiltrated with mononuclear cells. (E) ERK expression in same field as in (D). ERK was diffusely expressed in cyst cells and adjacent tubules and cells. (F) Hematoxylin and eosin section of same field as (D) and (E). The cytoplasm of the P-ERK expressing cells in the field stain faint pink, whereas other mural cells stain dark pink. Curved line marks segment of renal tubule that has undergone cystic transformation. (G) Higher power view of the abrupt transition (*) between P-ERK expressing cells and cells in which P-ERK is not expressed. (H) Same view as (G) showing diffuse expression of ERK. (I) Same view as (G) and (H) shows hematoxylin and eosin staining of cells and adjacent tissues. There is a sharp boundary between normal-appearing cells and hyperplastic, P-ERK-expressing cells (*). This boundary is reflected in the thickened basement membrane beneath the P-ERK expressing cells and the widened interstitium containing abnormal numbers of mononuclear cells. Markers = 20 μm. Kidney International 2003 63, 427-437DOI: (10.1046/j.1523-1755.2003.00755.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 Expression of phosphorylated extracellular-regulated kinase (P-ERK) in Western blots and kidneys from male and female Cy/+ and Cy/Cy. Western blots from Cy/+ littermates show that P-ERK expression was less in females than in males. Immunohistochemistry localized the expression of P-ERK in male and female kidneys to cells lining the cysts. In males, especially, the tubule basement membrane beneath cells expressing high levels of P-ERK was remarkably thickened and the subjacent interstitium was widened and contained mononuclear cells. Tubule basement membrane and interstitial changes were less marked in the females. The asterisks mark a segment of a cyst wall in which P-ERK expression is increased above that of most adjacent tubules. That segment is enlarged further in the adjacent panel. P-ERK expression was more widespread in Cy/Cy kidneys involving mural cells lining cysts, as well as noncystic tubules and there were occasional mononuclear cells in the interstitium. Tubule basement membrane changes were not as marked in the Cy/Cy as in the Cy/+ animals. Markers = 20 μm. Kidney International 2003 63, 427-437DOI: (10.1046/j.1523-1755.2003.00755.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 5 Expression of B-Raf and Raf-1 in 8-week-old-male +/+ and Cy/+. (A) B-Raf expression in same region shown in Figure 3d to i. B-Raf was diffusely expressed in the mural cells of cysts, including both phosphorylated extracellular-regulated kinase (P-ERK) expressing and P-ERK nonexpressing cells (see Figure 3d). (B) Lack of B-Raf expression after preincubation with immunizing peptide. (C) B-Raf expression in cortex of +/+ animal. Faint B-Raf expression in cells of distal and collecting tubules. (D) Significant B-Raf expression in cysts of Cy/+ kidney. Levels in the cells appear to be greater than in adjacent normal tubules. (E) Raf-1 expression in cortex of +/+ animal. No segments with preferential expression were detected. (F) Raf-1 expression in Cy/+. Levels were not increased in cyst epithelium. Marker = 20 μm. Kidney International 2003 63, 427-437DOI: (10.1046/j.1523-1755.2003.00755.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 6 Expression of Rap-1 and P-PKA in +/+ and Cy/+ kidneys. (A) Figure 5 C and E are from the same male +/+. Rap-1 was weakly expressed in the tubules of +/+. (B) Figure 5f is from the same male Cy/+. Rap-1 was expressed to a greater extent in cells lining cysts than in adjacent normal tubules of Cy/+ kidneys. (C) Phosphorylated protein kinase A (P-PKA) Cα was expressed in renal cell nuclei of +/+ kidneys. (D) P-PKA Cα was expressed in the nuclei of cystic epithelium. (E) Western blot of Rap-1, PKA RIIα and P-PKA RIIα in two +/+ and two Cy/+ littermates. Rap-1 expression was greater in Cy/+ than in +/+. P-PKA RIIα expression was greater in Cy/+ than in +/+. Kidney International 2003 63, 427-437DOI: (10.1046/j.1523-1755.2003.00755.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 7 Schematic model of adenylyl cyclase and tyrosine receptor kinase pathways in autosomal-dominant polycystic kidney disease (ADPKD) cyst epithelial cells. In renal cyst cells, extracellular-regulated kinase (ERK) is activated by two convergent pathways. Growth factors, for example, epidermal growth factor (EGF), may bind to receptor tyrosine kinase and activate the classical pathway to extracellular-regulated kinase (ERK). On the other hand, hormones, for example, vasopressin, that elevate cyclic adenosine monophosphate (cAMP) levels may activate ERK through the intermediacy of protein kinase A (PKA), Rap-1 and B-Raf. cAMP also stimulates fluid secretion into the cysts by promoting chloride transport through cystic fibrosis conductance regulator (CFTR). In this way the receptor tyrosine kinase and adenylyl cyclase pathways to ERK have an additive effect to accelerate the rate of cellular proliferation and the progressive enlargement of renal cysts. Kidney International 2003 63, 427-437DOI: (10.1046/j.1523-1755.2003.00755.x) Copyright © 2003 International Society of Nephrology Terms and Conditions